Apellis Pharmaceuticals shares owned by UBS Group
Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Apellis Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Apellis Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Apellis Pharmaceuticals by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $5.7M | 95k | 59.86 |
| 2023-09-30 | $147k | 3.9k | 38.04 |
| 2023-06-30 | $13M | 146k | 91.08 |
| 2023-03-31 | $6.9M | 104k | 65.96 |
| 2022-12-31 | $6.8M | 132k | 51.71 |
| 2022-09-30 | $2.1M | 30k | 68.31 |
| 2022-06-30 | $3.3M | 72k | 45.22 |
| 2022-03-31 | $5.8M | 115k | 50.80 |
| 2021-12-31 | $5.2M | 109k | 47.27 |
| 2021-09-30 | $6.5M | 197k | 32.96 |
| 2021-06-30 | $3.6M | 56k | 63.29 |
| 2021-03-31 | $502k | 12k | 42.91 |
| 2020-12-31 | $59k | 1.0k | 57.26 |
| 2020-09-30 | $9.0k | 293 | 30.72 |
| 2020-06-30 | $92k | 2.8k | 32.62 |
| 2020-03-31 | $347k | 13k | 26.82 |
| 2019-12-31 | $861k | 28k | 30.55 |
| 2019-09-30 | $743k | 31k | 24.09 |
| 2019-06-30 | $1.2M | 47k | 25.34 |
| 2019-03-31 | $182k | 9.4k | 19.46 |
| 2018-12-31 | $848k | 64k | 13.22 |
| 2018-09-30 | $464k | 26k | 17.83 |
| 2018-06-30 | $140k | 6.5k | 21.61 |
| 2018-03-31 | $115k | 5.2k | 22.15 |
| 2017-12-31 | $78k | 3.9k | 20.00 |